Krystal Biotech Inc
KRYS
Market Cap$3.82B
Close$
$205.93
53.1% upside
Current Fair Value
53.1% upsideUndervalued by 53.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.82 Billion |
|---|---|
| Enterprise Value | $3.49 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $3.12 |
| Beta | 0.78 |
| Outstanding Shares | 28,755,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 42.63 |
|---|---|
| PEG | -64.26 |
| Price to Sales | 16.82 |
| Price to Book Ratio | 4.2 |
| Enterprise Value to Revenue | 14.44 |
| Enterprise Value to EBIT | 54.94 |
| Enterprise Value to Net Income | 66 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data